Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators (Q47234119)
Jump to navigation
Jump to search
scientific article published in July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators |
scientific article published in July 2000 |
Statements
1 reference
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators (English)
1 reference
Hull RD
1 reference
Pineo GF
1 reference
Francis C
1 reference
Bergqvist D
1 reference
Fellenius C
1 reference
Soderberg K
1 reference
Holmqvist A
1 reference
Mant M
1 reference
Dear R
1 reference
Baylis B
1 reference
Mah A
1 reference
Brant R
1 reference
1 July 2000
1 reference
160
1 reference
14
1 reference
2208-2215
1 reference
Identifiers
1 reference